Introduction
It has been recognized that metabolism and active efflux in the small intestine act synergistically to reduce the oral bioavailability of substrate drugs. For example, cytochrome P450 (CYP) 3A4 (Preuksaritanont et al., 1996 , Zhang et al., 1999 , Doherty and Charman, 2002 , Kaminsky and Zhang, 2003 and P-glycoprotein/MDR1/ ABCB1 (Wacher et al., 1998 , Benet et al., 1999 , Suzuki and Sugiyama, 2000 , Kusuhara and Sugiyama, 2002 are expressed in the enterocytes and play an important role in reducing the drug absorption due to their similar substrate specificity. In addition, the synergistic action of conjugation and cellular extrusion into the intestinal lumen is also highlighted as a possible mechanism to account for the lower oral bioavailability of substrate drugs; substrate drugs are metabolized to their conjugate in enterocytes and then excreted into the lumen via efflux transporters (Suzuki and
Jejunum Perfusion Experiments
The perfusion experiments were performed according to methods described previously (Loria et al., 1976 , Yuasa et al., 1993 , Barthe et al., 1999 , Adachi et al., 2003 . Rats (240-280 g) and mice (23-28 g) were fasted overnight before the perfusion experiment with access to tap water only. Anesthesia was induced by ether for rats and by an i.v. injection of Nembutal (pentobarbital sodium, 50 mg/kg) for mice.
The animals were placed on a heating pad to maintain body temperature at 37 °C. The abdomen was opened by a midline longitudinal incision and an 8-10 cm jejunal segment was isolated and cannulated at both ends with plastic tubing. The segment was rinsed with phosphate buffered saline (PBS, pH 6.4). Saline was dropped onto the surgical area, which was then covered with a paper sheet to avoid loss of fluid.
The experiment was initiated by filling the segment with a 1 mL bolus of the perfusion solution followed by perfusion at 0.2 mL/min for rats and 0.1 mL/min for mice using an infusion pump (Harvard Apparatus Syringe Infusion Pump). The perfusion solution consisted of 20.1 mM Na 2 HPO 4 , 47.0 mM KH 2 PO 4 , 101 mM NaCl (pH 6.4) and contained 10 µM of 4MU or E3040 with a tracer concentration of 14 C-labeled inulin as a nonabsorbable marker (Yuasa et al., 1993 , Adachi et al., 2003 . The outflow perfusate was collected at 10 min intervals for 30 min. The length of the This article has not been copyedited and formatted. The final version may differ from this version. 
Data Analysis
The absorbed fraction (F a ) of each ligand was estimated according to the following equation which corrects for the volume change using [ 14 C]inulin as a nonabsorbable marker (Loria et al., 1976 , Yuasa et al., 1993 , Barthe et al., 1999 , Adachi et al., 2003 :
where C in,I and C out,I represent the concentration of [ 14 C]inulin in the inflow and outflow solutions, respectively, and C in and C out represent the 4MU and E3040 concentration in the inflow and outflow solutions, respectively.
The apparent membrane permeability clearance for the unit length of intestinal segments was calculated as follows (Yuasa et al., 1993 , Adachi et al., 2003 ;
where CL a,app is the apparent membrane permeability clearance, Q is the perfusion rate This article has not been copyedited and formatted. The final version may differ from this version. (0.1 and 0.2 mL/min), and L is the length of perfused segments.
The efflux rate of metabolites was calculated as follows (Chen and Pang, 1997);
where C out,M is the concentration of 4MU and E3040 metabolites and Q is the perfusion rate (0.1 and 0.2 mL/min).
Analytical methods
For the determination of 4MU, 4MU-G and 4MU-S, two methods were 
Results

Perfusion experiment in rats
In order to examine the role of Mrp2 in the efflux of conjugated metabolites, we performed perfusion of the intestinal lumen of EHBR in which Mrp2 expression is hereditarily defective using medium containing 4MU and E3040. Although no significant difference was observed between the two rat strains for the efflux of 4MU-G, 4MU-S and E3040-S (Figs. 1A, 1B and 2B), the efflux rate of E3040-G in EHBR was significantly lower than that in normal rats ( Fig. 2A ). The concentrations of conjugated metabolites of 4MU and E3040 in intestinal tissue were almost the same at the end of experiments between the two strains ( Table 1 ). The mass balance after perfusion experiments is summarized in Fig. 3 . In addition, there was no significant difference in the extent of absorption of 4MU and E3040 between the normal rats and EHBR (Figs. 1C and 2C) .
Perfusion experiment in mice
In order to examine the role of Bcrp1 in the efflux of conjugated metabolites formed in enterocytes, the intestinal lumen of Bcrp1 (-/-) and normal mice was perfused with medium containing 4MU and E3040. Efflux rate of intracellularly formed 4MU-G, 4MU-S and E3040-G into the lumen was calculated from the concentration of these conjugates in the outflow perfusate. In Bcrp1 (-/-) mice, the efflux rate of 4MU-G, 4MU-S and E3040-G was significantly lower than that in normal mice (Figs. 4A , 4B and 5A). Particularly, 4MU-S was not detectable in the outflow collected from Bcrp1 (-/-) mice (Fig. 4B ). It was also found that the amount of 4MU-G, 4MU-S and E3040-G associated with the intestinal tissue were almost the same at the end of experiments between two strains (Table 1) . In contrast to 4MU-S formation, the sulfate conjugate of E3040 was not detectable in either the outflow or the intestinal tissue in either Bcrp1 (-/-) or normal mice. The mass balance of 4MU and E3040 after perfusion experiments is summarized in Fig. 6 .
In addition, the apparent membrane permeability clearance (CL a,app ) of 4MU and E3040 were also calculated. The time profile for the CL a,app of 4MU and E3040
indicated that there is no significant difference in the extent of absorption of parent compounds between two strains (Figs. 4C and 5B).
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Discussion
It has been suggested that conjugating enzymes and efflux transporters may play an important role synergistically in extruding organic anions into the intestinal lumen (Suzuki and Sugiyama, 2000, Kusuhara and Sugiyama, 2002) . In the present study, we have focused on the function of Mrp2 and Bcrp1, apically located efflux transporters. It has been reported that both transporters are responsible for the cellular extrusion of glucuronide and sulfate conjugates (Suzuki and Sugiyama, 2000 , Nakatomi et al., 2001 , Suzuki, 2003 and that sulfate conjugates are much preferred substrates compared with glucuronides for Bcrp (Suzuki, 2003) . In addition, the expression level of MRP2 and BCRP in human small intestine was found to be much higher than MDR1 at the mRNA level (Taipalensuu, 2001) . Based on these results, we focused on the above two transporters as candidates involved in intestinal efflux of glucuronide and sulfate conjugates. In the present study, we have quantitatively determined the contribution of Mrp2 and Bcrp1 to the secretion of glucuronide and/or sulfate conjugates into the intestinal lumen by using an in situ intestinal perfusion technique in EHBR, Bcrp1 (-/-) mice and corresponding control animals. To clarify which efflux transporters are responsible for the efflux of conjugates, we also performed kinetic analyses. We previously demonstrated that the function of the Mdr1 product can be quantitatively estimated by this perfusion method (Adachi et al., 2003) .
The appearance of 4MU-S and 4MU-G in the outflow was almost the same between normal rats and EHBR, suggesting that Mrp2 is not responsible for the intestinal excretion of these conjugates (Figs. 1A and 1B) . It was also found that the intestinal excretion of E3040-G, but not that of E3040-S, was decreased in EHBR.
Collectively, although glucuronide conjugates are substrates for Mrp2, the functional significance of Mrp2 in intestinal glucuronide excretion depends on the substrates.
From this standpoint, the functional significance of Mrp2 in intestinal excretion of conjugated metabolites should also be discussed. In our previous investigation, it has been demonstrated that the efflux of intracellularly formed 2,4-dinitrophenyl-S-glutathione (DNP-SG), an Mrp2 substrate, into the intestinal lumen after intravenous administration of its precursor, 1-chloro-2,4-dinitrobenzene (CDNB), was significantly lower in EHBR than that in normal rats (Gotoh et al., 2000) .
This in vivo observation was further confirmed using Ussing chamber and everted intestinal sack studies. We have demonstrated that transport in the serosal to mucosal direction was 2-fold higher in SD rats compared with EHBR (Gotoh et al., 2000) . In addition, the serosal to mucosal transport was greater than that in the opposite direction and unidirectional transport disappeared in EHBR (Gotoh et al., 2000) . mice (Jonker et al., 2000) . In addition, the oral bioavailability of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine), a food carcinogen, was higher in Bcrp1 (-/-) mice compared to normal mice (van Herwaarden, 2003) . Jonker et al.
also demonstrated that mice lacking Bcrp1 become extremely sensitive to the dietary chlorophyll-breakdown product pheophorbide a, resulting in severe lethal phototoxic lesion on light-exposed skin (Jonker et al., 2002) . Bcrp1 transports pheophorbide a and is highly efficient in limiting its uptake from ingested food (Jonker et al., 2002) .
These observations strongly suggest that Bcrp restricts the absorption of toxic substrates in intestine. Furthermore, the fact that the renal clearance of E3040-S administrated by i.v. infusion is 2.4 fold lower in Bcrp1 (-/-) mice compared with normal mice suggests that Bcrp1also has a significant role in renal secretion (Mizuno et al., 2004) . It is unfortunate that we can't compare the results between kidney and intestine, since E-3040-S was not significantly formed in enterocytes (Fig. 5) .
Recently, the function of SNPs type BCRP proteins was extensively studied to explain the interindividual difference of pharmacokinetic profiles of substrates (Honjo et al., 2001 , Iida et al., 2002 , Zamber et al., 2003 . Further investigations are now underway to determine whether pharmacokinetics are influenced by BCRP genotypes in humans.
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Figure legend
Figure 2
Time profiles for the efflux of E3040-G and E-3040-S and absorption clearance of E3040 in EHBR and normal rats.
Small intestinal segments were perfused with medium containing 10 µM E3040
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